NextPlat Expects Approximately $55 Million in 2025 Revenue and Reports Strong Sequential Momentum with Cost Reductions and Margin Expansion Expected into 2026

Core Insights - NextPlat Corp anticipates approximately $55 million in revenue for 2025, with strong sequential momentum driven by cost reductions and margin expansion expected into 2026 [1] Financial Performance - The company expects improved operating results in the first half of 2026, with preliminary results indicating strong growth in profitable 340B and contracted fulfillment revenue [1] - A solid liquidity position is maintained, with a cash balance of approximately $13 million and working capital of about $15 million, alongside zero unsecured debt expected by December 31, 2025 [1] - Consolidated gross margin is projected to expand significantly, with an expected increase of 20%-25% in the first quarter of 2026 due to a shift towards higher-margin contracted services [1] Revenue Growth - Fourth quarter 2025 340B revenue is expected to increase by over 90% compared to the third quarter of 2025, driven by direct engagement initiatives and operational improvements [1] - Total prescription volume is anticipated to rise approximately 7% sequentially, reflecting growth in contracted prescription activity [1] Strategic Initiatives - The company is focused on operational process efficiency and cost reduction through structural overhead initiatives, including closing underutilized office space and personnel consolidation [1] - Management remains confident in the potential for rapid and profitable growth in 2026, emphasizing the importance of continued execution and capitalizing on opportunities [1]